Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Clinical trial NCT00706862 · UNKNOWN
Trial details
- NCT number
- NCT00706862
- Sponsor
- Agennix
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2015-06-01
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.